Status:
COMPLETED
Duloxetine in the Treatment of Stress Urinary Incontinence.
Lead Sponsor:
Eli Lilly and Company
Collaborating Sponsors:
Boehringer Ingelheim
Conditions:
Urinary Incontinence, Stress
Eligibility:
FEMALE
18-75 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to monitor the long term safety of duloxetine in the treatment of stress urinary incontinence.
Eligibility Criteria
Inclusion
- Women with predominant stress urinary incontinence.
- 7 or more incontinence episodes per week.
Exclusion
- Use of monoamine inhibitors.
Key Trial Info
Start Date :
April 1 2001
Trial Type :
INTERVENTIONAL
End Date :
May 1 2006
Estimated Enrollment :
458 Patients enrolled
Trial Details
Trial ID
NCT00191087
Start Date
April 1 2001
End Date
May 1 2006
Last Update
January 26 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon- Fri from 9AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician.
London, England, United Kingdom, SE3 7UQ